D
Denali Therapeutics Inc. DNLI
$15.49 $0.261.71% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue 15.19M 15.14M 99.79M 98.24M 14.36M
Gross Profit -15.19M -15.14M -99.79M -98.24M -14.36M
SG&A Expenses 32.27M 29.35M 30.06M 24.95M 25.19M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 134.96M 145.58M 129.85M 123.19M 116.59M
Operating Income -134.96M -145.58M -129.85M -123.19M -116.59M
Income Before Tax -124.12M -132.97M -114.69M -107.19M -99.03M
Income Tax Expenses -- -- 68.00K -- --
Earnings from Continuing Operations -124.12M -132.97M -114.75M -107.19M -99.03M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -124.12M -132.97M -114.75M -107.19M -99.03M
EBIT -134.96M -145.58M -129.85M -123.19M -116.59M
EBITDA -130.12M -143.26M -129.57M -120.92M -114.65M
EPS Basic -0.72 -0.78 -0.67 -0.63 -0.59
Normalized Basic EPS -0.45 -0.50 -0.44 -0.40 -0.37
EPS Diluted -0.72 -0.78 -0.67 -0.63 -0.59
Normalized Diluted EPS -0.45 -0.50 -0.44 -0.40 -0.37
Average Basic Shares Outstanding 171.45M 171.22M 170.09M 169.46M 168.83M
Average Diluted Shares Outstanding 171.45M 171.22M 170.09M 169.46M 168.83M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --